NovaDel Pharma Inc. (NovaDel) is a specialty pharmaceutical company developing oral spray formulations for a range of marketed pharmaceuticals. The Company has six product candidates in its pipeline. One of these product candidates, Zensana, is licensed to a marketing partner who will commercialize this product candidate. For its approved product, NitroMist and for ZolpiMist, NovaDel will most likely seek marketing partners to commercialize these three product candidates, as their distribution will require significant resources.